LEFTY1 Is a Dual-SMAD Inhibitor that Promotes Mammary Progenitor Growth and Tumorigenesis

Document Details

Document Type
Pub Defense Publication
Publication Date
Aug 01, 2020
Source ID
10.1016/j.stem.2020.06.017

Entities

People

  • Aaron M. Newman
  • Angera H Kuo
  • Dalong Qian
  • Frederick M Dirbas
  • George Somlo
  • Gunsagar S Gulati
  • Jane Antony
  • Jessica Lam
  • Kassandra Sanchez
  • Linus Li
  • Luuk S. Heitink
  • Maddalena Adorno
  • Maider Zabala
  • Michael F Clarke
  • Natesh Parashurama
  • Neethan A Lobo
  • Shaheen S Sikandar
  • Sopheak Sim
  • Stephen Quake
  • Tomer Kalisky

Organizations

  • Chan Zuckerberg Initiative
  • Congressionally Directed Medical Research Programs
  • Ludwig Institute for Cancer Research
  • National Institutes of Health
  • The Breast Cancer Research Foundation